Which closed-end funds own Avalyn Pharma Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $2.2M. Security type: common equity. Country: United States. CUSIP 05348Y105 · ISIN US05348Y1055 · ticker AVLN.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.06% | $649K | 19,705 sh | $1.1B | 7.8% discount | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 0.06% | $408K | 12,390 sh | $689M | 3.7% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.06% | $774K | 23,511 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.06% | $381K | 11,568 sh | $690M | 3.4% discount | Jun 30, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “AVLN” → · Compare two funds’ portfolios →